Retrophin Receives Workplace Excellence Award SAN DIEGO,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
360
Retrophin Receives Workplace Excellence Award

SAN DIEGO, May 23, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that it has been awarded the Peter Barron Stark Companies (PBS) Award for Workplace Excellence , which recognizes top-tier organizations committed to a culture of workplace excellence based upon employee feedback from the PBS Employee Opinion Survey. Retrophin’s survey results exceeded PBS’ “Best of the Best Benchmark,” which represents the top 25 percent of companies participating in the survey nationwide.

“We place the highest value on our team members’ input and we are thankful for their continuous efforts to help make Retrophin an employer of choice,” said Stephen Aselage, chief executive officer of Retrophin. “Engaged employees who are passionate about their work and dedicated to helping patients are vital to ultimately reaching our vision of being a leader within the rare disease community.”

PBS collects survey data from more than 300 companies and 100,000 employee opinions nationwide on topics such as work environment, clarity of purpose and goals, communication, commitment to quality, motivation, training and compensation. Only five to eight companies receive the Award for Workplace Excellence each year. Winners are often companies that value employee engagement when recruiting and attracting high-quality employees who are interested in maintaining workplace excellence.

About Retrophin

Retrophin is a biopharmaceutical company specializing in identifying, developing and delivering life-changing therapies to people living with rare diseases. The Company’s approach centers on its pipeline featuring late-stage assets targeting rare diseases with significant unmet medical needs, including fosmetpantotenate for pantothenate kinase-associated neurodegeneration (PKAN), a life-threatening neurological disorder that typically begins in early childhood, and sparsentan for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN), disorders characterized by progressive scarring of the kidney often leading to end-stage renal disease. Research in additional rare diseases is also underway, including a joint development arrangement evaluating the potential of CNSA-001 in phenylketonuria (PKU), a rare genetic metabolic condition that can lead to neurological and behavioral impairment. Retrophin’s R&D efforts are supported by revenues from the Company’s commercial products Chenodal ® , Cholbam ® and Thiola ® .

Retrophin.com About Peter Barron Stark Companies

For the past twenty-five years, clients have been partnering with Peter Barron Stark Companies to build organizational cultures where employees love to work and customers love to do business. To learn how Peter Barron Stark Companies helps transform organizations through customized services such as Employee Opinion Surveys, executive coaching, and leadership and employee training, visit  peterstark.com .

Contact: Chris Cline, CFA Vice President, Investor Relations & Corporate Communications 760-260-8600 IR@retrophin.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 278

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 744

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 481

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 74

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Anthropic Bears Get New Tools, But Daily Risk Bites

Updated Category News Views 72

A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 181

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 473

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 107

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 102

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
Luca's Campo Morado Denial Makes Guerrero Risk Clear

Updated Category News Views 94

A Dangerous Headline Needs More Than a Quick Rebuttal One ugly allegation can do more damage to a junior miner than a lousy quarter, especially when it involves a mine in Guerrero State and alleged criminal control. Luca Mining has flatly rejected Mexican media reports claiming that its Campo Morado Mine is controlled by a criminal organization. The company says the...

Continue Reading

Top 5 Most Recently Viewed Articles

Surge in Holiday Online Spending Driven by Mobile Shopping Trends

Updated Category News Views 145

The Rise of Mobile Shopping in the Holiday Season The 2024 holiday season has presented remarkable insights into consumer behavior, showcasing a notable 9% increase in online spending throughout the United States. This year's shopping frenzy, spanning from early November to the end of December, has seen consumers gravitate towards mobile devices for their purchases,...

Continue Reading
How Trump’s Tariffs Affect Your Daily Coffee Experience

Updated Category News Views 353

Exploring the Impact of Tariffs on Coffee Prices Recently, Sen. Elizabeth Warren (D-Mass.) criticized President Donald Trump during National Coffee Day, drawing attention to the rising costs of coffee that have resulted from his contentious tariff policies. While Trump expressed festive wishes associated with the day, Warren pointed out that these tariffs have caused...

Continue Reading
Replenish Nutrients: SRC Invests $15M, Aims for 5x Capacity

Updated Category News Views 49

Replenish Nutrients Aims to Change the Game When a $15 million investment surfaces in the world of regenerative agriculture, you know someone means business. SRC Agrominerals throwing cash at Replenish Nutrients could shake things up big time. Imagine an investment poised to bump Replenish's owned capacity by fivefold. It's not pocket change; it's laying down tracks for...

Continue Reading
Investing Opportunities Amid Securities Class Actions for 2025

Updated Category News Views 113

Understanding the Recent Class Action Lawsuits Law Offices of Howard G. Smith has alerted investors about ongoing class action lawsuits for several companies including Lantheus Holdings, Inc. (NASDAQ: LNTH), VF Corporation (NYSE: VFC), Fluor Corporation (NYSE: FLR), and Cytokinetics, Incorporated (NASDAQ: CYTK). Each case presents a unique opportunity for shareholders to...

Continue Reading
Silanes Market Projected to Reach $5.20 Billion by 2029

Updated Category News Views 77

Growth of the Silanes Market Towards 2029 The silanes market has been observed to be on a significant growth trajectory, with forecasts predicting an increase from USD 3.62 billion in 2024 to USD 5.20 billion by 2029. This remarkable rise is associated with a compound annual growth rate (CAGR) of 7.5% over the coming years. The driving force behind this expansion can be...

Continue Reading